(Total Views: 381)
Posted On: 02/09/2021 9:50:00 AM
Post# of 145247
Yes, so far / as of last tally, the number of deaths in CD12 is WAY low, imo. I've been using 28% mortality in SOC/placebo, if it turns out more like 32%, that bodes so extremely well for LLMab and the course of this pandemic.
(2)
(0)